Literature DB >> 16861936

Rapamycin delays but does not prevent recovery from acute renal failure: role of acquired tubular resistance.

Wilfred Lieberthal1, Robert Fuhro, Christopher Andry, Vimal Patel, Jerrold S Levine.   

Abstract

BACKGROUND: We reported that rapamycin impairs recovery after acute renal failure (ARF) in rats. The objective of this study was to determine if recovery will eventually occur after ARF despite continued rapamycin treatment.
METHODS: ARF was induced in rats by renal artery occlusion. Glomerular filtration rate (GFR), morphology, and tubular cell proliferation were assessed either 2, 4, 6, or 7 days later. Rats were treated daily with rapamycin or vehicle throughout the study. Cultured mouse proximal tubular (MPT) cells were used to compare the antiproliferative effects of rapamycin after exposure for 1 and 7 days.
RESULTS: Two days after ARF, GFR was reduced severely but comparably in vehicle and rapamycin rats. In controls, GFR began to increase after day 2 and was normal by day 6. In rapamycin rats, GFR did begin to improve until after day 4 and reached normal values by day 7. In controls, many proliferating tubular cells were present in outer medulla on day 2, after which proliferation progressively decreased. By contrast, in rapamycin rats, proliferating cells were sparse on day 2, but then increased substantially through days 4 and 6. Cultured MPT cells exposed to rapamycin for 7 days were approximately 10-fold more resistant to the antiproliferative effects of rapamycin than cells exposed for 1 day.
CONCLUSIONS: Rapamycin delays but does not prevent renal recovery after ARF. MPT cells become resistant to rapamycin after prolonged exposure. We speculate that the ultimate recovery of renal function after ARF is due to the development of acquired tubular cell resistance to rapamycin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16861936     DOI: 10.1097/01.tp.0000225772.22757.5e

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  23 in total

1.  New autophagy reporter mice reveal dynamics of proximal tubular autophagy.

Authors:  Ling Li; Zhao V Wang; Joseph A Hill; Fangming Lin
Journal:  J Am Soc Nephrol       Date:  2013-10-31       Impact factor: 10.121

Review 2.  Autophagy in acute kidney injury.

Authors:  Gur P Kaushal; Sudhir V Shah
Journal:  Kidney Int       Date:  2016-01-21       Impact factor: 10.612

Review 3.  Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.

Authors:  Daniel Fantus; Natasha M Rogers; Florian Grahammer; Tobias B Huber; Angus W Thomson
Journal:  Nat Rev Nephrol       Date:  2016-08-01       Impact factor: 28.314

4.  Kidney-intrinsic factors determine the severity of ischemia/reperfusion injury in a mouse model of delayed graft function.

Authors:  Longhui Qiu; Xingqiang Lai; Jiao-Jing Wang; Xin Yi Yeap; Shulin Han; Feibo Zheng; Charlie Lin; Zhuoli Zhang; Daniele Procissi; Deyu Fang; Lin Li; Edward B Thorp; Michael M Abecassis; Yashpal S Kanwar; Zheng J Zhang
Journal:  Kidney Int       Date:  2020-08-18       Impact factor: 10.612

5.  Preconditioning donor with a combination of tacrolimus and rapamacyn to decrease ischaemia-reperfusion injury in a rat syngenic kidney transplantation model.

Authors:  F Cicora; J Roberti; D Vasquez; D Guerrieri; N Lausada; P Cicora; G Palti; E Chuluyan; P Gonzalez; P Stringa; C Raimondi
Journal:  Clin Exp Immunol       Date:  2012-01       Impact factor: 4.330

Review 6.  Mitochondria in Sepsis-Induced AKI.

Authors:  Jian Sun; Jingxiao Zhang; Jiakun Tian; Grazia Maria Virzì; Kumar Digvijay; Laura Cueto; Yongjie Yin; Mitchell H Rosner; Claudio Ronco
Journal:  J Am Soc Nephrol       Date:  2019-05-10       Impact factor: 10.121

Review 7.  Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases.

Authors:  Vicente E Torres; Alessandra Boletta; Arlene Chapman; Vincent Gattone; York Pei; Qi Qian; Darren P Wallace; Thomas Weimbs; Rudolf P Wüthrich
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

Review 8.  Mammalian target of rapamycin (mTOR) as a potential therapeutic target in various diseases.

Authors:  Avileen Kaur; Saurabh Sharma
Journal:  Inflammopharmacology       Date:  2017-04-17       Impact factor: 4.473

9.  Telomerase, Autophagy and Acute Kidney Injury.

Authors:  Raymond C Harris; Huifang Cheng
Journal:  Nephron       Date:  2016-07-05       Impact factor: 2.847

10.  mTORC1 maintains renal tubular homeostasis and is essential in response to ischemic stress.

Authors:  Florian Grahammer; Nora Haenisch; Frederic Steinhardt; Lukas Sandner; Lukas Sander; Malte Roerden; Frederic Arnold; Tomke Cordts; Nicola Wanner; Wilfried Reichardt; Dontscho Kerjaschki; Markus A Ruegg; Michael N Hall; Pierre Moulin; Hauke Busch; Melanie Boerries; Gerd Walz; Ferruh Artunc; Tobias B Huber
Journal:  Proc Natl Acad Sci U S A       Date:  2014-06-23       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.